StockData

Cerenome vs INVO Fertility

CNSY and IVF side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CNSY and IVF compare

Cerenome and INVO Fertility are about the same size, with market caps of $4.8M and $5.5M.

INVO Fertility keeps more of each dollar of sales as profit, with a net margin of −92.3% compared with −621% at Cerenome.

Cerenome scores higher on the StockData Score (8 against 4 for INVO Fertility), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCNSYIVF
Size and price
Market cap$4.8M$5.5M
Share price$0.630$2.18
Change, 1 year−95.1%−88.7%
Change, 5 years−98.3%−100.0%
Beta (5Y)4.923.69
Employees2814
StockData Score
Total score8 (better)4
Valuation score3 (better)1
Growth score11
Performance score01 (better)
Health score4 (better)1
Dividend score00
Valuation
P/S1.1×0.7× (better)
P/B0.9×0.3× (better)
FCF yield−492%–
Fair value$2.14–
Margin of safety70.5%–
Growth
Revenue growth (TTM)−21.0%–
Revenue growth, 5Y average–45.8%
Profitability
Operating margin−628%−78.7% (better)
Net margin−621%−92.3% (better)
FCF margin−560%–
Return on equity−614%−149% (better)
Return on invested capital–−81.4%
Financial health
Debt / equity0.000.10 (better)
Interest coverage−1200.0×−5.2× (better)
Current ratio1.37 (better)0.71
Altman Z-score−58.37−5.41 (better)
Piotroski F-score4 (better)2
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions8.3%5.2%
Held by insiders4.2%5.2%
Insider net buying, 12 months$0 (better)−$6
Short interest, % of float11.6%0.32%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.